Flurbiprofen , ≥98.0%(HPLC) , 5104-49-4
                            Synonym(s):
(±)-2-Fluoro-α-methyl[1,1ʹ-biphenyl]-4-acetic Acid, U-27182;(±)-2-Fluoro-α-methyl-4-biphenylacetic acid;Flurbiprofen;Flurbiprofen - CAS 5104-49-4 - Calbiochem;L-790,330
                            
                        
                CAS NO.:5104-49-4
Empirical Formula: C15H13FO2
Molecular Weight: 244.27
MDL number: MFCD00079303
EINECS: 225-827-6
| Pack Size | Price | Stock | Quantity | 
| 1G | RMB47.20 | In Stock | 
                                                 | 
                                        
| 5G | RMB120.00 | In Stock | 
                                                 | 
                                        
| 25G | RMB508.00 | In Stock | 
                                                 | 
                                        
| 100G | RMB1519.20 | In Stock | 
                                                 | 
                                        
| others | Enquire | 
PRODUCT Properties
| Melting point: | 110-112 °C(lit.) | 
                                    
| Boiling point: | 376.2±30.0 °C(Predicted) | 
                                    
| Density | 1.1795 (estimate) | 
                                    
| storage temp. | Sealed in dry,Room Temperature | 
                                    
| solubility | methanol: soluble50mg/mL | 
                                    
| pka | pKa 3.80(H2O) (Uncertain) | 
                                    
| form | White solid | 
                                    
| color | white to off-white | 
                                    
| biological source | synthetic | 
                                    
| Water Solubility | 8mg/L(room temperature) | 
                                    
| Merck | 14,4199 | 
                                    
| InChI | InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18) | 
                                    
| InChIKey | SYTBZMRGLBWNTM-UHFFFAOYSA-N | 
                                    
| SMILES | FC1C=C(C=CC=1C1C=CC=CC=1)C(C)C(=O)O | 
                                    
| CAS DataBase Reference | 5104-49-4(CAS DataBase Reference) | 
                                    
| EPA Substance Registry System | [1,1'-Biphenyl]-4-acetic acid, 2-fluoro-?-methyl- (5104-49-4) | 
                                    
Description and Uses
Flurbiprofen synthesis was originally reported in 1974. During a study of the pharmacological properties of a large number of substituted phenylalkanoic acids, including ibuprofen and ibufenac, the most potent were found to be substituted 2-(4-biphenyl)propionic acids. Further toxicological and pharmacological studies indicated that flurbiprofen possessed the most favorable therapeutic profile, so it was selected for further clinical development. It was not marketed until 1987, when it was introduced as the sodium salt as Ocufen, the first topical NSAID indicated for ophthalmic use in the United States. The indication for Ocufen is the same as that for Profenal—that is, to inhibit intraoperative miosis induced by prostaglandins in cataract surgery.
A cyclooxygenase inhibitor
Safety
| Symbol(GHS) | ![]() GHS06  | 
                                    
| Signal word | Danger | 
| Hazard statements | H301 | 
| Precautionary statements | P264-P270-P301+P310+P330-P405-P501 | 
| Hazard Codes | T,C | 
| Risk Statements | 25-23/24/25 | 
| Safety Statements | 36/37/39-45 | 
| RIDADR | UN 2811 6.1/PG 2 | 
| WGK Germany | 3 | 
| RTECS | DU8341000 | 
| HazardClass | 6.1(b) | 
| PackingGroup | III | 
| HS Code | 29163990 | 
| Limited Quantities | 5.0 L (1.3 gallons) (liquid) or 5.0 kg (11 lbs) (solid) | 
| Excepted Quantities | Max Inner Pack (30g or 30ml) and Max Outer Pack (1Kg or 1L) | 







![1-(2-fluoro-[1,1''-biphenyl]-4-yl)ethan-1-one](https://img.chemicalbook.com/CAS/GIF/42771-79-9.gif)